Relevant bibliographies by topics / Hepatitis Injecting Drug user (IDU)

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Book chapters

Academic literature on the topic 'Hepatitis Injecting Drug user (IDU)'

Author: Grafiati
Published: 4 June 2025
Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hepatitis Injecting Drug user (IDU).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hepatitis Injecting Drug user (IDU)"

1

Abdul, Malik Alam Khan Jalal Khan. "FREQUENCY OF HEPATITIS B, HEPATITIS C AND HIV AMONG DRUG ADDICTS AT DOST FOUNDATION PESHAWAR." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 05, no. 08 (2018): 8097–101. https://doi.org/10.5281/zenodo.1406268.

Full text
Abstract:
<strong><em>Objectives</em></strong><em>: To find out the prevalence of Hepatitis B, Hepatitis C and HIV in drug addicts. </em> <strong><em>Study design: </em></strong><em>Cross sectional study</em> <strong><em>Study Setting and duration:</em></strong><em> Samples were collected from Dost Foundation non government nonprofit organization in Peshawar Khyber Pukhton Khowa</em> <em>Pakistan during the period of August 2017 to January2018.</em> <strong><em>Methodology: </em></strong><em>By ICT Rapid Strip Test 120 drug addicts were examined for the Deduction of HBsAg, Anti HCV and Anti HIV antibodi
APA, Harvard, Vancouver, ISO, and other styles
2

Wudneh, Ketema Moges. "MODELING INFECTIOUS DISEASE: DETERMINISTIC AND STOCHASTIC SACR MODELS." International Journal of Current Research and Modern Education (IJCRME) 5, no. 1 (2020): 27–34. https://doi.org/10.5281/zenodo.3906814.

Full text
Abstract:
Infectious diseases have been a great concern in human community. The transmission of hepatitis C occurs primarily through injecting drug user and it is mainly associated with the sharing of contaminated syringes or needles, although evidence for risk of hepatitis C infection through sharing of other injecting equipment is increasing. To measured seroprevalence of hepatitis virus (HCV) infection among injection drug users (IDU) using deterministic and stochastic models and investigate how the model parameters depend on the population size. The mathematical model quantiles the transmission of H
APA, Harvard, Vancouver, ISO, and other styles
3

O’DONOVAN, D., R. P. D. COOKE, R. JOCE, A. EASTBURY, J. WAITE, and K. STENE-JOHANSEN. "An outbreak of hepatitis A amongst injecting drug users." Epidemiology and Infection 127, no. 3 (2001): 469–73. http://dx.doi.org/10.1017/s0950268801006185.

Full text
Abstract:
This descriptive study investigated an outbreak of hepatitis A virus (HAV) infection among injecting drug users (IDUs) and their contacts. Twenty-seven cases of acute HAV infection were identified in a 5-month period. Connections with the local injecting drug using (IDU) population were established for 25 of the cases of whom 14 admitted to injecting drug use. HAV RNA genotyping revealed two HAV variants, closely related to variants found in Scandinavian IDUs and in South East Asia. The study demonstrates that once HAV enters the IDU population extensive outbreaks are possible. We recommend th
APA, Harvard, Vancouver, ISO, and other styles
4

SUTTON, A. J., S. A. McDONALD, N. PALMATEER, A. TAYLOR, and S. J. HUTCHINSON. "Estimating the variability in the risk of infection for hepatitis C in the Glasgow injecting drug user population." Epidemiology and Infection 140, no. 12 (2012): 2190–98. http://dx.doi.org/10.1017/s0950268812000489.

Full text
Abstract:
SUMMARYGlasgow (Scotland's largest city) has a high prevalence of injecting drug use and has one of the highest prevalences of hepatitis C virus (HCV) infection in injecting drug users (IDUs) in Western Europe. HCV prevalence data from surveys of Glasgow's IDUs from 1990 to 2007 were utilized and a model was applied that described the prevalence of HCV as a function of the rate (force) of infection. Force-of-infection estimates for HCV that may vary over time and injecting career length over a range of variables were investigated. New initiates to injecting were found to be at increased risk o
APA, Harvard, Vancouver, ISO, and other styles
5

Paul O’Shea, John. "Dolosigranulum Pigrum Bacteremia in an Injecting Drug User Associated with Methicillin Resistant Staphylococcus Aureus Endocarditis and Fungal Endophthalmitis." International Journal of Clinical Case Reports and Reviews 16, no. 04 (2024): 01–05. http://dx.doi.org/10.31579/2690-4861/380.

Full text
Abstract:
Dolosigranulum pigrum is a commensal bacterium of the upper respiratory tract. We present a case of D. Pigrum bacteremia, identified incidentally in a patient with a history of injecting drug use (IDU), chronic hepatitis C (HCV) and partially treated methicillin resistant staphylococcus aureus (MRSA) endocarditis, who presented with acute monocular vision loss. Workup was consistent with unilateral fungal endophthalmitis. The patient was initially treated with intravenous Voriconazole, Ceftriaxone and linezolid for 4 weeks with resolution of his symptoms. This case highlights the emerging role
APA, Harvard, Vancouver, ISO, and other styles
6

McDONALD, S. A., S. J. HUTCHINSON, C. SCHNIER, A. McLEOD, and D. J. GOLDBERG. "Estimating the number of injecting drug users in Scotland's HCV-diagnosed population using capture–recapture methods." Epidemiology and Infection 142, no. 1 (2013): 200–207. http://dx.doi.org/10.1017/s0950268813000617.

Full text
Abstract:
SUMMARYIn countries maintaining national hepatitis C virus (HCV) surveillance systems, a substantial proportion of individuals report no risk factors for infection. Our goal was to estimate the proportion of diagnosed HCV antibody-positive persons in Scotland (1991–2010) who probably acquired infection through injecting drug use (IDU), by combining data on IDU risk from four linked data sources using log-linear capture–recapture methods. Of 25 521 HCV-diagnosed individuals, 14 836 (58%) reported IDU risk with their HCV diagnosis. Log-linear modelling estimated a further 2484 HCV-diagnosed indi
APA, Harvard, Vancouver, ISO, and other styles
7

Barry, Michael P., Maria A. Corcorran, Judith I. Tsui, et al. "High Seroprevalence of Hepatitis C Virus Among Cisgender Women Who Exchange Sex in the Seattle, Washington Area." Substance Use &amp; Addiction Journal 45, no. 1 (2023): 81–90. http://dx.doi.org/10.1177/29767342231208936.

Full text
Abstract:
Background: Injection drug use (IDU) is a risk factor for hepatitis C virus (HCV) acquisition and occurs disproportionately among women who exchange sex (WES). However, little is known about HCV epidemiology in this population. We estimated HCV seroprevalence, identified correlates of HCV seropositivity, and characterized social networks by HCV serostatus and IDU history among WES in the Seattle, Washington, area. Methods: This was a secondary analysis of data from the 2016 National HIV Behavioral Surveillance survey in the Seattle, Washington area, a cross-sectional survey that used responden
APA, Harvard, Vancouver, ISO, and other styles
8

Onchong’a Robert, Mainga, Odari Okoth Eddy, Borus Kimutai Peter, et al. "Characterization of Hepatitis C virus circulating among injecting drug users (IDU) in Kilifi county, Kenya." Journal of Human Virology & Retrovirology 8, no. 2 (2020): 23–30. http://dx.doi.org/10.15406/jhvrv.2020.08.00217.

Full text
Abstract:
Background: Hepatitis C virus is a major global health problem estimated to infect over 170 million people globally with the most common route ofinfection being injecting drug use (IDU). Treatment for HCV infection has traditionally been shown to be genotype specific; however the available drugs are still expensive and out of reach in many developing countries. To improve on monitoring, there is need to continuously document the genotypic burden and epidemiology in different populations arises. Objectives: This study aimed to determine the circulating genotypes and link the data to the socio-d
APA, Harvard, Vancouver, ISO, and other styles
9

SUTTON, A. J., N. J. GAY, W. J. EDMUNDS, and O. N. GILL. "Modelling alternative strategies for delivering hepatitis B vaccine in prisons: the impact on the vaccination coverage of the injecting drug user population." Epidemiology and Infection 136, no. 12 (2008): 1644–49. http://dx.doi.org/10.1017/s0950268808000502.

Full text
Abstract:
SUMMARYSince 2001 hepatitis B vaccination has been offered to prisoners on reception into prisons in England and Wales. However, short campaigns of vaccinating the entire population of individual prisons have achieved high vaccination coverage for limited periods, suggesting that short campaigns may be a preferable way of vaccinating prisoners. A model is used that describes the flow of prisoners through prisons stratified by injecting status to compare a range of vaccination scenarios that describe vaccination on prison reception or via regular short campaigns. Model results suggest that vacc
APA, Harvard, Vancouver, ISO, and other styles
10

BUTT, Z. A., M. J. WILKINS, E. HAMILTON, D. TODEM, J. C. GARDINER, and M. SAEED. "Hepatitis B and C co-infection in HIV/AIDS population in the state of Michigan." Epidemiology and Infection 141, no. 12 (2013): 2604–11. http://dx.doi.org/10.1017/s0950268813000538.

Full text
Abstract:
SUMMARYA retrospective cohort study was conducted from 1 January 2006 to 31 December 2009 in Michigan to estimate the prevalence of HIV and hepatitis co-infection and identify associated factors. The prevalence of co-infection was 4·1% [95% confidence interval (CI) 3·8–4·5]. Multivariable logistic regression analysis revealed a significant association between co-infection and being male and: of Black race [odds ratio (OR) 2·0, 95% CI 1·2–3·6] and of Other race (OR 3·5, 95% CI 1·7–7·0) compared to Hispanic race. A significant association was found between co-infection and risk categories of blo
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Hepatitis Injecting Drug user (IDU)"

1

Milot, David-Martin. "Évaluation du besoin et de la pertinence de l'implantation d'un service d'injection supervisée en Montérégie." Thèse, 2014. http://hdl.handle.net/1866/11821.

Full text
Abstract:
This research project aimed to conduct a strategic analysis of the implementation of a supervised injecting facility (SIF) in Montérégie. Using a mixed design, we first completed a portrait of the injection drug user (IDU) population. We then explored the perceptions of IDU and stakeholders with regard to the relevance of implementing a SIF in the region. Although some similarities were found with the IDU populations of Montreal and the province of Quebec, this population in Montérégie is characterized by a lower frequency of injections in public, less homeless people and lower rates of HIV an
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Hepatitis Injecting Drug user (IDU)"

1

Jaffe, Harold W. "Heterosexual Men and Women and Injection Drug Users." In Dispatches from the AIDS Pandemic. Oxford University PressNew York, 2023. http://dx.doi.org/10.1093/oso/9780197626528.003.0005.

Full text
Abstract:
Abstract This chapter explores efforts to identify a known sexually transmitted infection (STI) that might serve as a model for the spread of the unidentified agent likely causing Kaposi’s sarcoma and opportunistic infections (KS/OI). The best model for KS/OI appeared to be hepatitis B virus (HBV). If this model were correct, KS/OI would be expected to occur in heterosexual men and women as well as in injection drug users (IDUs). Beginning in the summer of 1981, CDC began receiving reports of KS/OI in both heterosexuals and IDUs. Individual case investigations and epidemiologic studies indicat
APA, Harvard, Vancouver, ISO, and other styles
2

Manno, Valerio, Alice Maraschini, Susanna Conti, and Giada Minelli. "The Hospitalization Risk Profile of Opioids Users." In Evaluating the impact of Laws Regulating Illicit Drugs on Health and Society. BENTHAM SCIENCE PUBLISHERS, 2023. http://dx.doi.org/10.2174/9789815079241123010008.

Full text
Abstract:
Drug use-associated health problems are a complex phenomenon changing over time. Published studies regarding drug-related diseases are mainly based on emergency rooms data; moreover, most of these studies focus only on diseases related to injecting drug use (i.e. HIV, B and C Hepatitis). This chapter presents a study based on an exhaustive nationwide source on hospitalizations in Italy: the National Hospital Discharge Database (NHDB). The hospitalization risk profile of opioids user was studied, in terms of hospitalization rates and observed comorbidities; age and gender differences were taken
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Hepatitis Injecting Drug user (IDU)' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography